Cayman Chemical
Cayman Chemical is a US-based CRO providing services to the global pharmaceutical, biotechnology and academic research markets. Our diverse suite of services leverages a team of over 150 highly skilled scientists with expertise in bioanalysis, custom assay development, medicinal chemistry, structural biology, analytical chemistry and custom synthesis.
With in-house experts in immunology, biochemistry, cell biology, molecular biology, biomarker development, cellular metabolism and custom protein and antibody production, we offer a vast array of services and solutions to advance your project. Our broad range of services can be used individually as stand-alone services or combined to support larger, fully integrated research and development projects, supported by our numerous in-house capabilities and core facilities.
Bioanalysis & Assay Development
- Biological sample analysis
- High-throughput screening
- Lipidomics
- Immunology
- NETosis
- Immunological screening
- Immunopeptidome profiling
- Cellular metabolism
- Proteomic & PTM analysis
- Custom assay development
- Antibody production
- Protein production
- Cell & molecular biology
Medicinal Chemistry & Structural Biology
- Virtual high-throughput screening (vHTS)
- Structure-based drug design (SBDD)
- In Silico drug design/computer-aided drug design (CADD)
- Biophysical characterization
- Protein crystallization
- Structure determination
- Sample analysis
- MS-based method development
- MS support for pharmacokinetics
- Complex organic chemistry
- Stable isotopic labelling
- Custom libraries & mixtures
For more information about our service offerings, visit our website at www.caymanchem.com/services
Read interviews with our in-house experts to learn more about our service capabilities and how they can help accelerate your next project.
Meet the Expert: Biomarker Development
Meet the Expert: Immunopeptidome Profiling
Meet the Expert: Mitochondrial/Cellular Metabolism Profiling
Meet the Expert: Lipidomic Profiling Services
Seropositivity Testing for SARS-CoV-2 Neutralizing Antibodies
Characterization of Peptides Associated with Molecules of the Major Histocompatibility Complex
Characterizing a Better Uncoupler
Mitochondrial Fuel Flexibility Assessment in a Tumor-Relevant Model
Screening for Drug Induced Mitochondrial Dysfunction
A Novel Series of Selective Agonists Evaluated against Rattus Norvegicus EP4 Receptor
Histone H3 citrullination as a measure of PAD4 activity/inhibition
High-Throughput Flow Cytometric Screening of a Kinase Inhibitor Library for Apoptosis Induction
View our complete list of application notes here.
Assessing SARS-CoV-2 Neutralizing Antibody Activities in Sera with a Cell-based ELISA
Development and Validation of a 2’3’-cGAMP ELISA
Robust and Versatile Workflow for Routine Lipidomics Analysis
Cancer Neoepitope Identification in Soluble HLA from Patient Plasma
Macrophage Clearance of Neutrophil Extracellular Traps (NETs)
Characterization of Metabolic Changes Induced by Anticancer Drugs in MCF-7 and MDA-MB-231 Cell Lines
Screening a Kinase Inhibitor Library for Mitochondrial Dysfunction
Methods in Citrullination and Analysis of Recombinant Human Histones
View our complete list of scientific posters here.
Contact Information